SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-007395
Filing Date
2024-02-28
Accepted
2024-02-28 07:26:14
Documents
15
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20240228.htm   iXBRL 8-K 29990
2 EX-1.1 exhibit11-8xk.htm EX-1.1 291230
  Complete submission text file 0001628280-24-007395.txt   506234

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20240228.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20240228_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20240228_pre.xml EX-101.PRE 13045
16 EXTRACTED XBRL INSTANCE DOCUMENT naut-20240228_htm.xml XML 2826
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 24690166
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)